Trust Company’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$487 Sell
36
-2
-5% -$24 ﹤0.01% 760
2026
Q1
$228 Hold
38
﹤0.01% 866
2025
Q4
$272 Buy
+38
New +$300 ﹤0.01% 834
2022
Q2
Sell
-22
Closed -$1K 336
2022
Q1
$1K Hold
22
﹤0.01% 335
2021
Q4
$1K Hold
22
﹤0.01% 312
2021
Q3
$1K Buy
+22
New +$704 ﹤0.01% 302

Other funds holding OGN

Trust Company's OGN Position: Q2 2026 in Review

Trust Company reduced its Organon & Co (OGN) stake by 5.3% in Q2 2026, selling an estimated $24 and leaving 36 shares worth $487. The position accounts for ﹤0.01% of the portfolio, ranked #760.

Trust Company first reported a position in OGN in Q3 2021 and has held it in 6 quarters since. The position peaked at $1K in Q1 2022. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Trust Company held 36 shares of Organon & Co worth $487 as of Q2 2026.
  • Trust Company sold 2 Organon & Co shares in Q2 2026, an estimated $24.
  • Organon & Co made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #760 holding.
  • Trust Company first reported a position in Organon & Co in Q3 2021 and has held it in 6 quarters since.
  • Trust Company's Organon & Co position peaked at $1K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.